Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05928052 · ClinicalTrials.gov registry record · NA
Spinal Cord Stimulation to Shorten Ventilator Dependence in ARDS Patients
A NA study of Respiratory Distress Syndrome, sponsored by University of California, Los Angeles.
- Recruiting
- Registry status
- NA
- Development phase
- 20
- Enrollment target
- 1
- Study location
NCT05928052: Recruiting NA study of Respiratory Distress Syndrome, sponsored by University of California, Los Angeles.
NCT05928052 is a NA study of Respiratory Distress Syndrome that is actively recruiting participants, run by University of California, Los Angeles. The registered enrollment target is 20 participants, below the 232-participant average among 8 other Respiratory Distress Syndrome trials with a reported enrollment target (91% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05928052, a NA study of Respiratory Distress Syndrome, is actively recruiting participants, sponsored by University of California, Los Angeles.
- RECRUITING
- Registry status
- NA
- Development phase
- 20 participants
- Enrollment target
- 1
- Study location
Study Summary
This is an early phase, proof-of-concept clinical trial assessing the safety and feasibility of non-invasive spinal cord stimulation to prevent respiratory muscle atrophy in mechanically ventilated ARDS patients. The investigators will recruit 10 elective surgery patients (surgery cohort) and 10 ARDS patients (ARDS cohort) for this study. A non-invasive, alpha-prototype Restore Technology stimulator using hydrogel surface electrodes will be used to stimulate the spinal cord at the cervical or thoracic level.
Primary Outcome
Although unlikely, we will record and monitor the number of stimulation-induced adverse events per case and per cohort. Our goal is to have an overall AE rate of less than 10% per cohort.
Conditions Studied
Interventions
- DEVICE Transcutaneous Biopac Electrical Stimulator
Study Locations (1)
California
- University of California, Los Angeles - Los Angeles
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 20 participants |
| Start Date | 2023-04-18 |
| Est. Completion | 2029-01-06 |
| Phase | NA |
What NCT05928052 shows while recruiting
NCT05928052 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 20 participants, a relatively small participant target, below the 232-participant average among 8 other Respiratory Distress Syndrome trials with a reported enrollment target (91% lower).
The record links to 1 condition, with Respiratory Distress Syndrome appearing as the primary indexed condition, and to 1 intervention - of which Transcutaneous Biopac Electrical Stimulator is the first listed.
NCT05928052 reports a single indexed study location in California.
Frequently Asked Questions
What is clinical trial NCT05928052 about?
NCT05928052 is a clinical study titled "Spinal Cord Stimulation to Shorten Ventilator Dependence in ARDS Patients". This is an early phase, proof-of-concept clinical trial assessing the safety and feasibility of non-invasive spinal cord stimulation to prevent respiratory muscle atrophy in mechanically ventilated ARDS patients. The investigators will recruit 10 elective surgery patients (surgery cohort) and 10 ARD...
What is the current status of trial NCT05928052?
This trial is currently recruiting. It is a NA study. The enrollment target is 20 participants. The study started on 2023-04-18. Estimated completion is 2029-01-06.
What conditions does trial NCT05928052 study?
This clinical trial studies the following conditions: Respiratory Distress Syndrome.
What interventions are being tested in trial NCT05928052?
The interventions under investigation include: Transcutaneous Biopac Electrical Stimulator (DEVICE).
Who is sponsoring clinical trial NCT05928052?
This trial is sponsored by University of California, Los Angeles, which has 897 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05928052 being conducted?
This trial has 1 study location across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Respiratory Distress Syndrome
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT05928052's enrollment target sits among peer trials
20 8th of 8 higher than 1 of 8 other Respiratory Distress Syndrome trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Respiratory Distress Syndrome trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Non Inferiority Trial Investigating Surfactants Administered Via MIST
RECRUITING · Phase 4
-
Forced Oscillometry in Infants With Bronchopulmonary Dysplasia
RECRUITING
-
Safety and Efficacy of APC-0101 in Preterm Infants With Respiratory Distress Syndrome
RECRUITING · Phase 3
-
The Budesonide in Babies (BiB) Trial
ACTIVE NOT RECRUITING · Phase 3
-
Phase I Study of Vasoactive Intestinal Peptide in Patients With Acute Respiratory Distress Syndrome and Sepsis
COMPLETED · Phase 1
-
The Safety and Efficacy of Lucinactant for Inhalation in Premature Neonates 26 to 32 Weeks Gestational Age
COMPLETED · Phase 2
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00573339 · 20 participants
Cardiac Magnetic Resonance Imaging (MRI) Normal Reference Control Group Testing
- NCT00692939 · 20 participants · Phase 1
Autologous Stem Cell Transplantation for Crohn's Disease
- NCT00967785 · 20 participants · Phase 1
A Phase I Study of Mozobil in the Treatment of Patients With WHIMS
- NCT01406691 · 20 participants · Phase 4
Light Flashes to Treat Delayed Sleep Phase Disorder (DSPD)
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI